Tracking skin cancer patients starting systemic treatment
Part of Cancer, Skin clinical trials.
This study follows patients newly diagnosed with cutaneous squamous cell carcinoma (a type of skin cancer) who are beginning systemic treatment (medicine that affects the whole body). Researchers want to understand how these treatments work and track patient outcomes over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with primary cutaneous squamous cell carcinoma (skin cancer)
- You are about to start or have just started your first systemic treatment (chemotherapy, immunotherapy, or targeted therapy)
- You are 18 years or older
- You have not received any other systemic treatments before for this cancer
- You have health insurance coverage
- You are willing to share your personal medical data with the research team
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two strategies after surgery for a type of skin cancer (cutaneous squamous cell carcinoma) that has a high chance of coming back. One strategy gives radiation therapy to the area, while the other just watches and checks for any signs of recurrence. The goal is to see if radiation can prevent the cancer from returning.
This trial tests a combination of two drugs—an immunotherapy (pucotenlimab) and a targeted therapy (becotatug vedotin)—for advanced skin cancer that cannot be removed surgically or has spread. It aims to see if the combination helps shrink tumors or slow the cancer.
This study uses a test to see if a type of skin cancer called high-risk cutaneous squamous cell carcinoma has spread to lymph nodes. The goal is to learn more about how to detect spread early, which could help guide treatment decisions.
This study looks at whether radiation therapy after surgery helps people with a high-grade type of skin cancer called squamous cell carcinoma. It may help doctors understand who benefits most from this additional treatment.
This study uses information from a European registry to learn how real-world treatments work for advanced non-melanoma skin cancers. It may help doctors improve care in the future, especially for people who have had surgery and radiation or who cannot have curative treatments.
This study looks at how doctors stage (classify the extent of) a type of skin cancer called cutaneous squamous cell carcinoma. You may be helping researchers by allowing your clinical data to be used for research.
Hear when a new Cutaneous Squamous Cell Carcinoma (CSCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.